[Association of maternal diabetes mellitus and UCP2 gene polymorphisms with congenital heart disease in offspring: a case-control study]

Zhongguo Dang Dai Er Ke Za Zhi. 2020 Oct;22(10):1092-1099. doi: 10.7499/j.issn.1008-8830.2004011.
[Article in Chinese]

Abstract

Objective: To study the association of maternal diabetes mellitus (DM), uncoupling protein 2 (UCP2) gene polymorphisms, and their interaction with the risk of congenital heart disease (CHD) in offspring.

Methods: A hospital-based case-control study was conducted. A total of 464 mothers of children with CHD alone who were diagnosed in Hunan Children's Hospital from March 2018 to August 2019 were enrolled as the case group. A total of 504 mothers of healthy children who were hospitalized during the same period and did not have any deformity were enrolled as the control group. A questionnaire survey was performed to collect the information on exposure. Venous blood samples (5 mL) were collected from the mothers to detect UCP2 gene polymorphisms. A multivariate logistic regression analysis was used to investigate the association of maternal DM, UCP2 gene polymorphisms, and their interaction with CHD in offspring.

Results: After control for confounding factors, the multivariate logistic regression analysis showed that mothers with gestational DM (OR=2.96, 95%CI: 1.57-5.59), a history of gestational DM (OR=3.16, 95%CI: 1.59-6.28), and pregestational DM (OR=4.52, 95%CI: 2.41-8.50) significantly increased the risk of CHD in offspring (P<0.05). The polymorphisms of the UCP2 gene at rs659366 (T/C vs C/C: OR=1.49, 95%CI: 1.02-2.16; T/T vs C/C: OR=2.77, 95%CI: 1.67-4.62) and rs660339 (A/A vs G/G: OR=2.19, 95%CI: 1.34-3.58) were significantly associated with risk of CHD in offspring (P<0.05). The interaction analysis showed an interaction between the polymorphisms of the UCP2 gene at rs659366 and rs660339 and maternal DM in the development of CHD (P<0.05).

Conclusions: Maternal DM, UCP2 gene polymorphisms, and their interaction are associated with the development of CHD in offspring.

目的: 探讨母亲糖尿病、解偶联蛋白2基因(UCP2)多态性及两者的交互作用与子代先天性心脏病(CHD)的关系。

方法: 采用以医院为基础的病例对照研究,选择2018年3月至2019年8月在湖南省儿童医院确诊的464例单纯CHD患儿的母亲为病例组,选择同期住院、无先天畸形的504例患儿的母亲为对照组。通过问卷调查,收集相关暴露信息,同时采集母亲静脉血5 mL,用于UCP2基因多态性检测。采用多因素logistic回归分析探讨母亲糖尿病、UCP2基因多态性及两者交互作用与子代CHD的关联性。

结果: 多因素logistic回归分析显示,在控制混杂因素后,患有妊娠期糖尿病(OR=2.96,95% CI:1.57~5.59)、有妊娠期糖尿病史(OR=3.16,95% CI:1.59~6.28)和妊娠前患有糖尿病(OR=4.52,95% CI:2.41~8.50)均显著增加子代CHD的风险(P < 0.05)。母亲UCP2基因两个位点rs659366(T/C vs C/C:OR=1.49,95% CI:1.02~2.16;T/T vs C/C:OR=2.77,95% CI:1.67~4.62)和rs660339(A/A vs G/G:OR=2.19,95% CI:1.34~3.58)的多态性与子代CHD的风险存在关联(P < 0.05)。交互作用分析显示,UCP2基因两个位点(rs659366和rs660339)的多态性与母亲糖尿病在子代CHD发生中存在交互作用(P < 0.05)。

结论: 母亲糖尿病、UCP2基因多态性及其交互作用与子代CHD发病相关。

MeSH terms

  • Case-Control Studies
  • Child
  • Diabetes, Gestational*
  • Female
  • Heart Defects, Congenital* / genetics
  • Humans
  • Polymorphism, Genetic
  • Pregnancy
  • Uncoupling Protein 2 / genetics*

Substances

  • UCP2 protein, human
  • Uncoupling Protein 2

Grants and funding

国家自然科学基金项目(81803313);湖南省重点研发计划项目(2018SK2063);湖南省托举人才项目(2020TJ-N07);湖南省自然科学基金项目(2018JJ2551)